VanderbiltHealth.com: For Patients and Visitors
Vanderbilt University Medical Center: For Employees, Researchers, and Students

In The News

Study explores race differences of lung cancer risk

Vanderbilt research scientist Melinda Aldrich, Ph.D., MPH, has been awarded a National Institutes of Health Academic Career Award to investigate some of the genetic secrets behind a greater risk of lung cancer among African-Americans compared with other racial and ethnic groups. [Read More]


Regional variations in benign lung disease -- VICC News

Stephen A. Deppen, M.A., M.S., presented a study that show rates of benign lung disease diagnosis varied widely by state following surgery for lung cancer. The results could have an impact on clinical guidelines and health policy for lung cancer screening.[Read More]


Grogan discusses minimally invasive lung cancer surgery -- Cure magazine

Dr. Eric Grogan discusses the need to weigh the benefits of minimally invasive surgery against surgical outcomes. [Read More]


Thoracic study finds obesity increases OR time -- Vanderbilt Reporter

Drs. Eric Grogan and Jamii St. Julien find that obesity significantly increases time to complete surgical procedures, thereby also increasing costs. [Read More]


Ancestry impacts smoking risks for lungs -- Aliquots, Vanderbilt Reporter

Dr. Melinda Aldrich and colleagues evaluated lung function, tobacco smoking exposure and genetic ancestry in a large population of African-Americans to determine if African ancestry modifies smoking’s impact on lung function. Her findings were reported in the June 21 issue of PLoS One[Read More]


Study reveals diagnostic value of FDG-PET with non-small cell lung cancer varies widely - ASCO Daily News – 2012

Dr. Eric Grogan presented results from a study on the accuracy of FDG-PET to diagnose lung cancer at the Annual Meeting of the American Society of Clinical Oncology. His presentation won “Best of ASCO” and will be presented at 2012 Best of ASCO Meetings to be held in Chicago, Boston and San Diego. [Read More]


Surgical removal of tumor made possible through lung cancer screening - Vanderbilt Reporter

Kathy Leiser first heard about Vanderbilt-Ingram Cancer Center’s lung cancer screening trial through a sponsorship ad on WPLN radio last summer. The Nashville office technology saleswoman and grandmother of three had stopped smoking in 2009, but she knew her smoking history put her at risk for lung cancer. [Read More]


Thoracic and Neurological Surgeons Work Side-by-Side to Heal Cancer Patient - Vanderbilt Reporter

The first surgery Eric Grogan, M.D., and Matthew McGirt, M.D., performed together lasted 18 hours. Grogan, a thoracic surgeon, carefully cut away the baseball-sized lung tumor that had wrapped around patient Ronald Denton’s aorta, subclavian artery and esophagus and removed the upper lobe of the lung. [Read More] 


Lung nodule surgery not always “futile” - Vanderbilt Reporter

The gold standard for definitive diagnosis of a lung nodule is surgical removal (resection). However, between 10 percent and 30 percent of suspicious nodules are benign. Because thoracic operations are highly invasive and pose significant risks, these operations have been labeled “unnecessary” or “futile.” [Read More]


Less invasive lung cancer surgery studied- Vanderbilt Reporter

For years, the standard treatment for some early lung cancers was to remove the entire affected lobe. The recurrence of cancer was low, but the procedure was invasive and unnecessarily removed normal lung tissue not affected by the tumors.

Vanderbilt's Department of Thoracic Surgery and the Vanderbilt-Ingram Cancer Center have joined a National Cancer Institute clinical trial to determine if patients could remain equally as disease free with less invasive, lung-sparing surgery. [Read More]


Progress on lung cancer blood test - Aliquots, Vanderbilt Reporter

Up to 30 percent of lung nodules evaluated surgically (biopsy) turn out to be benign, indicating a need for noninvasive diagnostic tests to help reduce these unnecessary surgeries, which carry low but real risks.

Eric Grogan, M.D., M.P.H., Pierre Massion, M.D., and colleagues evaluated the accuracy of a blood protein signature – which they previously found to be associated with lung cancer – in distinguishing benign from malignant lung nodules in 58 patients. [Read More]


Study seeks to improve early diagnosis, treatment of lung cancer - Vanderbilt Reporter

It can be called the lung cancer paradox: A 65-year-old man has a small lung nodule, too small and difficult to locate without performing a thoracotomy — a major surgery with significant risk of complications.

Since the nodule is small, the doctors wait, conducting CT scans every six months looking for any changes. Nothing happens until the two-year mark when the nodule grows suddenly and significantly. [Read More] 

Copyright © 2014 by Vanderbilt University Medical Center    |    1211 Medical Center Drive    |    Nashville, TN 37232    |    (615) 322-5000
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
This page was last updated June 18, 2012 and is maintained by Vicki Gann